Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities.
A considerable interest exists worldwide in the development of live attenuated oral vaccines against diarrhoeal diseases. In addition to vaccination against the corresponding pathogens, such vaccine strains can be used as carriers for the expression of protective antigens from other organisms. The antigenic repertoire of a given vaccine strain may thereby be extended, potentially leading to a bivalent vaccine. The lipopolysaccharide is known to be a major antigenic surface component of bacterial enteric pathogens. The feasibility of the development of combined vaccines based on live attenuated carriers expressing two O-serotype specificities is illustrated here by the development of candidate live oral vaccines against Shigella sonnei using Salmonella typhi and Vibrio cholerae as carriers. Various factors that may limit the potential of such hybrid strains as bivalent vaccines are discussed.
Viret
J F
JF
Swiss Serum and Vaccine Institute, Berne.
Favre
D
D
D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology; D003967:Diarrhea / Q000517:prevention & control*; D004756:Enterobacteriaceae Infections / Q000517:prevention & control*; D005240:Feasibility Studies; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology; D051379:Mice; D019081:O Antigens; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011817:Rabbits; D014613:Vaccines, Attenuated / Q000276:immunology; D017778:Vaccines, Combined / Q000276:immunology
D001428:Bacterial Vaccines; D008070:Lipopolysaccharides; D019081:O Antigens; D011135:Polysaccharides, Bacterial; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined